相似文献
1
Setbacks in Alzheimer research demand new strategies, not surrender.
PLoS Med. 2018 Feb 27;15(2):e1002518. doi: 10.1371/journal.pmed.1002518. eCollection 2018 Feb.
2
Mads Krogsgaard Thomsen. Interview by Asher Mullard.
Nat Rev Drug Discov. 2014 Feb;13(2):96-7. doi: 10.1038/nrd4238.
3
[Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
Lakartidningen. 2012;109(26-28):1280-1.
4
Precompetitive consortia in biomedicine--how are we doing?
Nat Biotechnol. 2013 Nov;31(11):979-85. doi: 10.1038/nbt.2731.
5
David Haslam. Interview by Asher Mullard.
Nat Rev Drug Discov. 2013 Jul;12(7):500. doi: 10.1038/nrd4053. Epub 2013 Jun 14.
6
Open access chemical and clinical probes to support drug discovery.
Nat Chem Biol. 2009 Jul;5(7):436-40. doi: 10.1038/nchembio0709-436.
7
Precompetitive research: a new prescription for drug development?
Clin Pharmacol Ther. 2010 May;87(5):521-3. doi: 10.1038/clpt.2010.28.
8
Precompetitive activity to address the biological data needs of drug discovery.
Nat Rev Drug Discov. 2014 Feb;13(2):83-4. doi: 10.1038/nrd4230.
9
Q&A: Bernard Munos.
Nature. 2016 May 12;533(7602):S59. doi: 10.1038/533S59a.
10
Translational regenerative medicine research: essential to discovery and outcome.
Regen Med. 2007 May;2(3):227-9. doi: 10.2217/17460751.2.3.227.
引用本文的文献
1
The value of supportive care: A systematic review of cost-effectiveness of non-pharmacological interventions for dementia.
PLoS One. 2023 May 12;18(5):e0285305. doi: 10.1371/journal.pone.0285305. eCollection 2023.
2
Bacillus Calmette-Guérin in Immuno-Regulation of Alzheimer's Disease.
Front Aging Neurosci. 2022 Jun 27;14:861956. doi: 10.3389/fnagi.2022.861956. eCollection 2022.
3
Novel Design of Neuropeptide-Based Drugs with β-Sheet Breaking Potential in Amyloid-Beta Cascade: Molecular and Structural Deciphers.
Int J Mol Sci. 2022 Mar 5;23(5):2857. doi: 10.3390/ijms23052857.
4
Comparison of Antihypertensive Drug Classes for Dementia Prevention.
Epidemiology. 2020 Nov;31(6):852-859. doi: 10.1097/EDE.0000000000001245.
5
Pharmacotherapy of Alzheimer's Disease: Seeking Clarity in a Time of Uncertainty.
Front Pharmacol. 2020 Mar 24;11:261. doi: 10.3389/fphar.2020.00261. eCollection 2020.
6
Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
PLoS One. 2019 Nov 7;14(11):e0224433. doi: 10.1371/journal.pone.0224433. eCollection 2019.
7
Individualized clinical management of patients at risk for Alzheimer's dementia.
Alzheimers Dement. 2019 Dec;15(12):1588-1602. doi: 10.1016/j.jalz.2019.08.198. Epub 2019 Oct 31.
8
Predicting cognitive resilience from midlife lifestyle and multi-modal MRI: A 30-year prospective cohort study.
PLoS One. 2019 Feb 19;14(2):e0211273. doi: 10.1371/journal.pone.0211273. eCollection 2019.
9
The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.
Alzheimers Dement. 2018 Dec;14(12):1663-1673. doi: 10.1016/j.jalz.2018.08.004. Epub 2018 Nov 13.
本文引用的文献
1
Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial.
PLoS Med. 2018 Feb 6;15(2):e1002500. doi: 10.1371/journal.pmed.1002500. eCollection 2018 Feb.
2
Traumatic brain injury and the risk of dementia diagnosis: A nationwide cohort study.
PLoS Med. 2018 Jan 30;15(1):e1002496. doi: 10.1371/journal.pmed.1002496. eCollection 2018 Jan.
3
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
N Engl J Med. 2018 Jan 25;378(4):321-330. doi: 10.1056/NEJMoa1705971.
4
Contribution of cognitive performance and cognitive decline to associations between socioeconomic factors and dementia: A cohort study.
PLoS Med. 2017 Jun 26;14(6):e1002334. doi: 10.1371/journal.pmed.1002334. eCollection 2017 Jun.
5
Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.
PLoS Med. 2017 Mar 28;14(3):e1002272. doi: 10.1371/journal.pmed.1002272. eCollection 2017 Mar.
6
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
PLoS Med. 2017 Mar 21;14(3):e1002258. doi: 10.1371/journal.pmed.1002258. eCollection 2017 Mar.
7
Potentially modifiable lifestyle factors, cognitive reserve, and cognitive function in later life: A cross-sectional study.
PLoS Med. 2017 Mar 21;14(3):e1002259. doi: 10.1371/journal.pmed.1002259. eCollection 2017 Mar.
8
Development of an adaptive, personalized, and scalable dementia care program: Early findings from the Care Ecosystem.
PLoS Med. 2017 Mar 21;14(3):e1002260. doi: 10.1371/journal.pmed.1002260. eCollection 2017 Mar.
9
Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: A community-based cohort study.
PLoS Med. 2017 Mar 14;14(3):e1002251. doi: 10.1371/journal.pmed.1002251. eCollection 2017 Mar.
10
What is the Relationship of Traumatic Brain Injury to Dementia?
J Alzheimers Dis. 2017;57(3):667-681. doi: 10.3233/JAD-161002.
Zotero 插件